Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Podcast: KHN’s ‘What The Health?’ ‘Conscience’ Rules, Rx Prices and Still More Medicare
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
Drug Industry Patents Go Under Senate Judiciary Committee’s Microscope
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
Feds Want To Show Health Care Costs On Your Phone, But That Could Take Years
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
A Big Hearing For ‘Medicare-For-All’ — In A Small Room
In an unusual move, the House Rules Committee, instead of one of the panels that typically oversee health policy, held the first House hearing in a decade about converting the U.S. to a government-financed health care system.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Estados debaten prohibir popular pesticida que afectaría el desarrollo infantil
Varios estudios han relacionado la exposición prenatal al clorpirifos con disminución de peso al nacer, bajo coeficiente intelectual, déficit de atención y otros problemas de desarrollo en niños.
States Weigh Banning A Widely Used Pesticide Even Though EPA Won’t
The pesticide chlorpyrifos has been linked to developmental problems in children. Some state and federal lawmakers want the chemical banned, but federal regulators are fighting to keep it on the market.
Podcast: KHN’s ‘What The Health?’ The Abortion Wars Rage On
Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss the latest news about women’s reproductive health policy and the latest skirmish in the debate over “Medicare-for-all”: how hospitals should be paid.